Short answer
PRO DEX INC (PDEX) filed an 8-K current report with the SEC on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 fiscal 2026 results for the three months ended September 30, 2026 announced October 29, 2026.
PRO DEX INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 fiscal 2026 results for the three months ended September 30, 2026 announced October 29, 2026
- Full financial performance details available in Exhibit 99.1 press release
Item EX-99.1 · Exhibit EX-99.1
- Fiscal Q1 revenue $20.6M, up 11%, driven by $3.3M higher medical-device revenue and $511,000 from APM
- Gross margin expanded to 33% from 29%, producing gross profit growth of 28% to $6.9M
- Operating income rose 13% to $3.5M despite operating expenses increasing 48% to $3.3M
- Net income fell to $3.0M, or $0.92 diluted EPS, versus $4.7M and $1.40, reflecting lower investment gains
- Monogram validation-unit shipments expected later this fiscal year, creating potential future customer traction with Zimmer Biomet
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PRO DEX INC 8-K filings
Get the next PDEX 8-K as it lands
Follow PDEX for push alerts, or ask the research agent what this filing means.